Satellos Bioscience Inc stock is traded at $6.70, with a volume of 19,222. It is up +5.51% in the last 24 hours and down -11.14% over the past month. Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
Previous Close:
$6.35
Open:
$6.57
24h Volume:
19,222
Relative Volume:
0.47
Market Cap:
$142.15M
Revenue:
-
Net Income/Loss:
-$28.50M
P/E Ratio:
-
EPS:
-$1.81
Net Cash Flow:
-$25.87M
1W Performance:
0.00%
1M Performance:
-11.14%
6M Performance:
-12.99%
1Y Performance:
0.00%
1-Day Range:
$6.42$6.70
1-Week Range:
$6.10$6.75
52-Week Range:
$5.44$13.39
Satellos Bioscience Inc Stock (MSLE) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS